ANALYSIS OF THE RELEVANCE OF DETECTION OF ADVANCED CANDIDIASIS ON THE BACKGROUND OF HIV AND THE SPECIFICS OF ITS CONTROL
Article Sidebar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Main Article Content
Abstract:
Candidiasis, which occurs in people with weakened immune systems, is the most common fungal infection in patients diagnosed with HIV, which worsens the course of the disease and negatively affects the quality and life expectancy of patients. This infection mainly affects the skin and mucous membranes of organs and systems, causing severe peeling, which is often found in an invasive form. This infection, which develops in more than 90% of HIV-infected people, is more pronounced in the pre-active art and later stages of AIDS. In this review, the main task is to analyze the epidemiology of candidiasis that has developed against the background of HIV, and the relevance of its detection and the specifics of its control. It is known that the development of candidiasis is caused by several Candida species, and the identification of each pathogen causing candidiasis at the molecular level is considered important.
Article Details
How to Cite:
References:
Anwar KP, Malik A, Subhan KH. Profile of candidiasis in HIV infected patients. Iran J Microbiol. 2012 Dec;4(4):204-9.
Asgari, F., Majidi, A., Koohpayehzadeh, J., Etemad, K., and Rafei, A. (2015). Oral hygiene status in a general population of Iran, 2011: A key lifestyle marker in relation to common risk factors of non-communicable diseases. Int. J. Health Policy Manag. 4, 343–352. doi: 10.15171/ijhpm.2015.18
Divakar DD, Al Kheraif AA, Ramakrishnaiah R, Khan AA, Sandeepa NC, Alshahrani OA, et al. Oral manifestations in human immunodeficiency virus infected pediatric patients receiving and not receiving antiretroviral therapy: a cross sectional study. Methods. (2015) 59:152–8. doi: 10.13112/PC.2015.23
Dwi Murtiastutik, Cita Rosita Sigit Prakoeswa and Indah Setiawati Tantular, Fluconazole Resistant Oral Candidiasis on HIV Patient – What Other Drug can We Choose? A Case Report, J. Pure Appl. Microbiol., 2020; 14(1): 31-36. https://doi.org/10.22207/JPAM.14.1.06
Hosain Pour A, Salari S, Ghasemi Nejad Almani P. Oropharyngeal candidiasis in HIV/AIDS patients and non-HIV subjects in the Southeast of Iran. Curr Med Mycol. 2018 Dec;4(4):1-6. doi: 10.18502/cmm.4.4.379.
Keyvanfar, A., Najafiarab, H., Talebian, N. et al. Drug-resistant oral candidiasis in patients with HIV infection: a systematic review and meta-analysis. BMC Infect Dis 24, 546 (2024). https://doi.org/10.1186/s12879-024-09442-6
Lu, S.-Y. (2021). Oral candidosis: Pathophysiology and best practice for diagnosis, classification, and successful management. J. Fungi 7:555. doi: 10.3390/jof7070555
Malele Kolisa Y, Yengopal V, Shumba K, Igumbor J. The burden of oral conditions among adolescents living with HIV at a clinic in Johannesburg, South Africa. PLoS One. (2019) 14:e0222568. doi: 10.1371/journal.pone.0222568
Osaigbovo, I. I., Lofor, P. V., and Oladele, R. O. (2017). Fluconazole resistance among oral Candida isolates from people living with HIV/AIDS in a Nigerian tertiary hospital. J. Fungi 3:69. doi: 10.3390/jof3040069
Rajadurai, S. G., Maharajan, M. K., Veettil, S. K., and Gopinath, D. (2021). Comparative efficacy of antifungal agents used in the treatment of oropharyngeal candidiasis among HIV-infected adults: A systematic review and network meta-analysis. J. Fungi 7:637. doi: 10.3390/jof7080637
Rakhmanova A.G., Bubochkin A.B., Vinogradova A.N., Dmitrieva M.I., Agamalieva A.D. Candidiasis in patients with HIV / AIDS. HIV Infection and Immunosuppressive Disorders. 2015;7(1):60-68. (In Russ.) https://doi.org/10.22328/2077-9828-2015-7-1-60-68
Song, Y., Chen, X., Yan, Y., Wan, Z., Liu, W., and Li, R. (2020). Prevalence and antifungal susceptibility of pathogenic yeasts in China: A 10-year retrospective study in a teaching hospital. Front. Microbiol. 11:1401. doi: 10.3389/fmicb.2020.01401
Taverne-Ghadwal L, Kuhns M, Buhl T, Schulze MH, Mbaitolum WJ, Kersch L, Weig M, Bader O, Groß U. Epidemiology and Prevalence of Oral Candidiasis in HIV Patients From Chad in the Post-HAART Era. Front Microbiol. 2022 Feb 17;13:844069. doi: 10.3389/fmicb.2022.844069.
Terças, A. L., Marques, S. G., Moffa, E. B., Alves, M. B., de Azevedo, C. M., Siqueira, W. L., et al. (2017). Antifungal drug susceptibility of Candida species isolated from HIV-positive patients recruited at a public hospital in São Luís, Maranhão, Brazil. Front. Microbiol. 8:298. doi: 10.3389/fmicb.2017.00298
Vila, T., Sultan, A. S., Montelongo-Jauregui, D., and Jabra-Rizk, M. A. (2020). Oral candidiasis: A disease of opportunity. J. Fungi 6:15.